Chemed (CHE) Cash from Investing Activities (2009 - 2026)

Chemed has reported Cash from Investing Activities for 18 years, with the latest figure at -$28.2 million in Q2 2026.

• Cash from Investing Activities for Q2 2026 came in at -$28.2 million, down 82.4% year-over-year; the trailing twelve-month figure through Jun 2026 was -$96.2 million (down 59.84% YoY), and the FY2025 annual result was -$59.3 million, up 58.77% from the prior year.
• Cash from Investing Activities grew to -$28.2 million in Q2 2026, from -$37.8 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$11.7 million in Q4 2023 and troughed at -$93.5 million in Q2 2024.
• A 5-year average of -$21.6 million and a median of -$15.7 million in 2025 frame the typical range for Cash from Investing Activities.
• The widest annual swing landed in 2024, when Cash from Investing Activities sank 465.88%; it then jumped 83.44% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$19.5 million in 2022, then jumped by 40.12% to -$11.7 million in 2023, then slipped by 7.28% to -$12.5 million in 2024, then fell by 27.4% to -$16.0 million in 2025, then slumped by 77.03% to -$28.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$28.2 million in Q2 2026, -$37.8 million in Q1 2026, and -$16.0 million in Q4 2025.